Company Profile
Oragenics Stock Price, News & Analysis
- Ticker:
- OGEN
- Exchange:
- 美国证券交易所
- Sector:
- Biotechnology
- Location:
- Headquartered in the United States and listed on 美国证券交易所, Oragenics is followed within the biotech universe for its exposure to catalyst-driven execution.
Stock performance
0.59 USD (+1.73%)
Close
Last updated: June 23, 2026 at 00:00
2.65M USD
Market cap
Why the stock is moving
OGEN is trading with a steady catalyst profile while investors wait for the next headline that changes the story.
Company overview
Business overview
Oragenics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
Geographic Base and Sector Classification
Headquartered in the United States and listed on 美国证券交易所, Oragenics is followed within the biotech universe for its exposure to catalyst-driven execution.
Business Model Characteristics
Oragenics follows a catalyst-driven model where the market watches how the company turns development work into repeatable value creation.
Position Within the Biotechnology Landscape
Compared with more mature healthcare peers, Oragenics sits closer to the development side of the biotechnology landscape, where timing around data and approvals matters most.
Future catalysts
Recent news
The five most recent feed items are shown below in reverse chronological order.
- 01
- 02
ORAGENICS PROVIDES INVESTOR UPDATE
Source: Oragenics
- 03
- 04
- 05
Oragenics Completes Approximately $16.5 Million Offering
Source: Oragenics
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Oragenics (OGEN)?
Oragenics (OGEN) most recently closed at 0.59 USD, a +1.73% move versus the previous session.
What is the market cap of Oragenics (OGEN)?
Oragenics currently has a market capitalization of 2.65M USD on BioPharmSignal.
What does Oragenics do?
Oragenics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
On which exchange is OGEN stock listed?
Oragenics (OGEN) is associated with 美国证券交易所, Headquartered in the United States and listed on 美国证券交易所, Oragenics is followed within the biotech universe for its exposure to catalyst-driven execution., Biotechnology.
What is Oragenics?
Oragenics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs.
Which conditions is Oragenics targeting with Oragenics?
Oragenics is a biopharmaceutical company focused on advancing a pipeline of therapeutic programs. Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.
What is Investors?
Investors usually track how clinical data, regulatory milestones, and launch execution change the story over time.